215 related articles for article (PubMed ID: 10073370)
1. Outcome in schizophrenia: beyond symptom reduction.
Meltzer HY
J Clin Psychiatry; 1999; 60 Suppl 3():3-7; discussion 8. PubMed ID: 10073370
[TBL] [Abstract][Full Text] [Related]
2. Effectiveness and cost of atypical versus typical antipsychotic treatment for schizophrenia in routine care.
Stargardt T; Weinbrenner S; Busse R; Juckel G; Gericke CA
J Ment Health Policy Econ; 2008 Jun; 11(2):89-97. PubMed ID: 18509216
[TBL] [Abstract][Full Text] [Related]
3. [Medico-economic study of LĂ©ponex (clozapine) in the Bordeaux Charles Perrens Hospital Center].
Bret P; Jolivel C; Bret MC; Veylit S; Martin C; Garcia P
Encephale; 1998; 24(4):365-77. PubMed ID: 9809242
[TBL] [Abstract][Full Text] [Related]
4. The effects of clozapine on cognitive functioning in schizophrenia.
McGurk SR
J Clin Psychiatry; 1999; 60 Suppl 12():24-9. PubMed ID: 10372607
[TBL] [Abstract][Full Text] [Related]
5. New vs. old antipsychotics: the Texas experience.
Reid WH
J Clin Psychiatry; 1999; 60 Suppl 1():23-5; discussion 28-30. PubMed ID: 10037167
[TBL] [Abstract][Full Text] [Related]
6. Evaluating the effects of antipsychotics on cognition in schizophrenia. Collaborative Working Group on Clinical Trial Evaluations.
J Clin Psychiatry; 1998; 59 Suppl 12():35-40. PubMed ID: 9766618
[TBL] [Abstract][Full Text] [Related]
7. Annual health outcomes and treatment costs for schizophrenia populations.
Mauskopf JA; David K; Grainger DL; Gibson PJ
J Clin Psychiatry; 1999; 60 Suppl 19():14-9; discussion 20-2. PubMed ID: 10507276
[TBL] [Abstract][Full Text] [Related]
8. New antipsychotic agents: emerging clinical profiles.
Buckley PF
J Clin Psychiatry; 1999; 60 Suppl 1():12-7; discussion 28-30. PubMed ID: 10037165
[TBL] [Abstract][Full Text] [Related]
9. Atypical antipsychotics in the managed care era.
Loebel AD; Botts SR; Feldman BI
Am J Manag Care; 1998 Jan; 4 Suppl():S37-50; quiz S51-2. PubMed ID: 10181074
[TBL] [Abstract][Full Text] [Related]
10. Randomized controlled trial of the effect on Quality of Life of second- vs first-generation antipsychotic drugs in schizophrenia: Cost Utility of the Latest Antipsychotic Drugs in Schizophrenia Study (CUtLASS 1).
Jones PB; Barnes TR; Davies L; Dunn G; Lloyd H; Hayhurst KP; Murray RM; Markwick A; Lewis SW
Arch Gen Psychiatry; 2006 Oct; 63(10):1079-87. PubMed ID: 17015810
[TBL] [Abstract][Full Text] [Related]
11. [The impact of antipsychotic medication on the incidence and the costs of inpatient treatment in people with schizophrenia: results from a prospective observational study].
Kilian R; Angermeyer MC
Psychiatr Prax; 2004 Apr; 31(3):138-46. PubMed ID: 15042477
[TBL] [Abstract][Full Text] [Related]
12. [Medico-economic evaluation of treatment with clozapine versus treatment with previous neuroleptics].
Geronimi-Ferret D; Lesay M; Barges-Bertocchio MH; Cornet-Bonnefont M; Robert H
Encephale; 1997 Sep; 23 Spec No 4():24-31. PubMed ID: 9417402
[TBL] [Abstract][Full Text] [Related]
13. Should clozapine continue to be restricted to third-line status for schizophrenia?: a decision-analytic model.
Wang PS; Ganz DA; Benner JS; Glynn RJ; Avorn J
J Ment Health Policy Econ; 2004 Jun; 7(2):77-85. PubMed ID: 15208468
[TBL] [Abstract][Full Text] [Related]
14. Treatment-resistant schizophrenia: reviewing the options and identifying the way forward.
Hellewell JS
J Clin Psychiatry; 1999; 60 Suppl 23():14-9. PubMed ID: 10625195
[TBL] [Abstract][Full Text] [Related]
15. Cost analysis of treating schizophrenia with amisulpride: naturalistic mirror image study.
Surguladze S; Patel A; Kerwin RW; Knapp M; Travis MJ
Prog Neuropsychopharmacol Biol Psychiatry; 2005 May; 29(4):517-22. PubMed ID: 15866352
[TBL] [Abstract][Full Text] [Related]
16. Clozapine for refractory schizophrenia: the Illinois experience.
Buckman RW; Malan RD
J Clin Psychiatry; 1999; 60 Suppl 1():18-22; discussion 28-30. PubMed ID: 10037166
[TBL] [Abstract][Full Text] [Related]
17. Methods of cost-effectiveness analysis in the evaluation of new antipsychotics: implications for schizophrenia treatment.
Neumann PJ
J Clin Psychiatry; 1999; 60 Suppl 3():9-14; discussion 15. PubMed ID: 10073371
[TBL] [Abstract][Full Text] [Related]
18. [Atypical pharmacologic characteristics of an antipsychotic drug: clozapine].
Gosselin O; Ribeyre JM; Kahn JP
Encephale; 1997 Sep; 23 Spec No 4():2-6. PubMed ID: 9417400
[TBL] [Abstract][Full Text] [Related]
19. The pharmacoeconomics of clozapine: a review.
Meltzer HY; Cola PA
J Clin Psychiatry; 1994 Sep; 55 Suppl B():161-5. PubMed ID: 7961564
[TBL] [Abstract][Full Text] [Related]
20. Impact of drug treatment history on comparative effectiveness research in schizophrenia.
McCombs J; Zolfaghari S; Ganapathy V
Value Health; 2011; 14(5):679-86. PubMed ID: 21839406
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]